Stay updated on FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases
Sign up to get notified when there's something new on the FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases page.
Latest updates to the FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedDifference0.2%
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.0%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check54 days agoChange DetectedThe latest updates include the posting of results on November 20, 2024, detailing the efficacy of Ibrexafungerp (SCY-078) in treating various invasive fungal diseases, with specific metrics on participant responses and survival rates at defined timepoints.SummaryDifference98%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference5%
Stay in the know with updates to FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases
Enter your email address, and we'll notify you when there's something new on the FURI Clinical Trial: Ibrexafungerp in Resistant Fungal Diseases page.